Menu Menu

INMB    Inmune Bio Inc    1711754    
Income Statement
Revenue 14,000
Net Income -12,093,000
Profit Margin -86378.57%

Balance Sheet
Current Assets 35,851,000
Assets 52,782,000
Current Liabilities 13,823,000
Liabilities 14,107,000
Equity 38,675,000
Shares Out 19,782,000

Cash Flow Statement
Operating Cash Flow -22,348,000

Market Analysis
Market Cap 107,499,732
Price 6.45
BVPS 1.96
PB 3.22
EPS -2.06
PS 1919.64
Dividends
Jan Feb Mar
Apr May Jun
Jul Aug Sep
Oct Nov Dec

Earnings
Jan Feb Mar
2.65
Apr May Jun
5/09 -0.61
Jul Aug Sep
8/01 -0.50
Oct Nov Dec
10/31

Find a discrepancy? The most accurate way to find company fundamental data is to view INMB documents filed with the SEC.


INMB Filings       Clear



Find balance sheet, income statement, market analysis, and dividend information by typing the ticker symbol of a company.

Ticker: